AstraZeneca Pharma India Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has AstraZeneca Pharma India Limited's balance sheet done over the years? Its assets were worth $10,780,300,000 last year, which is more than in the previous period. 34% of AstraZeneca Pharma India Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $3,661,100,000, which means an increase by 6% compared compared to last year.
Debt to Assets
| 2011 | 3086819768 | 1.28B | 41.79% |
|---|---|---|---|
| 2012 | 3420842213 | 1.52B | 44.67% |
| 2015 | 4115927938 | 2.60B | 63.37% |
| 2016 | 4057210863 | 2.49B | 61.55% |
| 2018 | 4605400000 | 2.13B | 46.38% |
| 2019 | 5618000000 | 2.61B | 46.46% |
| 2020 | 7063600000 | 3.41B | 48.41% |
| 2021 | 7747100000 | 3.18B | 41.12% |
| 2022 | 8565600000 | 3.45B | 40.3% |
| 2024 | 10780300000 | 3.66B | 33.96% |
ASTRAZEN.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 5.05B | 4.48B | 3.52B | 835M | 1.73B | 1.13B | 62.00M | 14.38M | 536.50M | 853.90M |
Short term investments | 0 | 123.10M | 56.56M | 1.69B | 0 | 116.8M | 700M | 225M | 0 | 0 |
Net receivables | 1.53B | 982.85M | 912.16M | 956M | 912.1M | 586.8M | 890.59M | 0 | 0 | 0 |
Inventory | 2.27B | 1.40B | 1.59B | 1.65B | 1.18B | 1.13B | 767.29M | 861.30M | 750.96M | 572.02M |
Other current assets | 461.3M | 187.44M | 154.03M | 290.7M | 221.7M | 274.8M | 1.12B | 9.67M | 688.13M | 769.57M |
Total current assets | 9.32B | 7.05B | 6.18B | 5.42B | 4.04B | 3.20B | 2.68B | 2.63B | 1.97B | 2.19B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 648.4M | 766.9M | 849.8M | 960.1M | 835.7M | 800M | 1.03B | 1.13B | 901.82M | 513.87M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 21.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | -93.8M | 43.3M | 39M | 28.6M | 2.5M | -699.99M | -224.99M | 0 | 0 |
Other non-current assets | 571.2M | 672.8M | 564.4M | 533.9M | 501.5M | 270.7M | 1.03B | 576.37M | 365.78M | 302.02M |
Total non-current assets | 1.45B | 1.50B | 1.55B | 1.64B | 1.57B | 1.39B | 1.37B | 1.48B | 1.44B | 891.31M |
Total assets | 10.78B | 8.56B | 7.74B | 7.06B | 5.61B | 4.60B | 4.05B | 4.11B | 3.42B | 3.08B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 496.1M | 306.9M | 1.07B | 1.02B | 0 | 16M | 87.49M | 1.41B | 0 | 0 |
Short term debt | 18.1M | 36.1M | 35.1M | 25.4M | 0 | 0 | 0 | 6.06M | 0 | 0 |
Total current liabilities | 3.57B | 3.32B | 3.03B | 3.27B | 2.58B | 2.06B | 2.48B | 2.59B | 1.52B | 1.25B |
| Non-current liabilities: | ||||||||||
Long term debt | 27.8M | 50.2M | 86.3M | 93M | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 62.1M | 75M | 64.1M | 53.8M | 9.6M | 48.9M | 12.66M | 10.18M | 5.44M | 36.23M |
Total non-current liabilities | 89.9M | 125.2M | 150.4M | 146.8M | 20.2M | 66.6M | 12.66M | 10.18M | 5.44M | 36.23M |
Total liabilities | 3.66B | 3.45B | 3.18B | 3.41B | 2.61B | 2.13B | 2.49B | 2.60B | 1.52B | 1.28B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |